Meta-Analysis
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 107995
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.107995
Table 2 Pooled results of all available studies in measured outcomes
Measured outcomes
No. studies
No. patients
Model (fixed/random)
OR/HR
95%CI
P (overall test)
Heterogeneity
Begg test
Egger test
I2
P value
Pr >|z1
P >|t|1
Overall survival9IHCC: 6296PHCC: 6716RandomHR = 1.020.83-1.24P = 0.8858%0.0110.137
Node metastasis6IHCC: 651PHCC: 817FixedOR = 0.690.55-0.88P = 0.0030% 0.850.4690.492
Neural invasion3IHCC: 435PHCC: 382RandomOR = 0.710.11-4.64P = 0.7296%< 0.0000110.671
Vascular invasion3IHCC: 453PHCC: 384RandomOR = 0.820.28-2.38P = 0.7290%< 0.000110.657
Overall survival8IHCC: 6227DCC: 1153RandomHR = 1.070.18-1.36P = 0.5956%0.030.5330.355
Node metastasis5IHCC: 522DCC: 445FixedOR = 0.330.23-0.45P = 0.0000170%0.0090.8160.631
Neural invasion-----------
Vascular invasion3IHCC: 661DCC: 250FixedOR = 1.661.22-2.28P = 0.00191%< 0.00010.3330.263
Overall survival10PHCC: 6833DCC: 1330RandomHR = 1.060.92-1.22P = 0.4241%0.0910.352
Node metastasis7PHCC: 989DCC: 622RandomOR = 0.480.29-0.81P = 0.00580%< 0.00010.3810.952
Neural invasion3PHCC: 573DCC: 250RandomOR = 2.350.76-7.28P = 0.1490%< 0.00010.3330.065
Vascular invasion-----------